• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中的乙酰胆碱释放:单终板水平的调节

Acetylcholine release in myasthenia gravis: regulation at single end-plate level.

作者信息

Plomp J J, Van Kempen G T, De Baets M B, Graus Y M, Kuks J B, Molenaar P C

机构信息

Department of Physiology, University of Leiden, Netherlands.

出版信息

Ann Neurol. 1995 May;37(5):627-36. doi: 10.1002/ana.410370513.

DOI:10.1002/ana.410370513
PMID:7755358
Abstract

In myasthenia gravis, loss of acetylcholine receptors at motor end-plates is induced by antireceptor autoantibodies. At end-plates in rats in which myasthenia gravis-like symptoms are induced by chronic treatment with alpha-bungarotoxin, acetylcholine release is increased. Within muscles from such rats there is a strong correlation between the increase of acetylcholine release at an end-plate and the loss of postsynaptic acetylcholine receptors, caused by the toxin. The question is whether upregulation of acetylcholine release is a clinically relevant compensatory mechanism in myasthenia gravis or only a feature of the animal model using alpha-bungarotoxin. We investigated electrophysiologically the in vitro acetylcholine release at end-plates of muscles from patients with myasthenia gravis and rats with experimental autoimmune myasthenia gravis where acetylcholine receptor reduction is caused by autoantibody attack. In both human and rat autoimmune myasthenic muscle, the mean quantal content was considerably increased compared with control levels. At each individual myasthenic end-plate, the increase in quantal content appeared to be correlated with the reduction of the amplitude of the miniature end-plate potential. This finding suggests the existence of an important compensatory mechanism in myasthenia gravis, in which retrograde acting factors (i.e., from muscle fiber to nerve terminal) upregulate acetylcholine release.

摘要

在重症肌无力中,运动终板处的乙酰胆碱受体因抗受体自身抗体而减少。在通过长期用α-银环蛇毒素处理诱导出类似重症肌无力症状的大鼠的终板处,乙酰胆碱释放增加。在这类大鼠的肌肉中,终板处乙酰胆碱释放的增加与由毒素导致的突触后乙酰胆碱受体的减少之间存在很强的相关性。问题在于乙酰胆碱释放的上调是重症肌无力中一种具有临床相关性的代偿机制,还是仅仅是使用α-银环蛇毒素的动物模型的一个特征。我们用电生理学方法研究了重症肌无力患者以及实验性自身免疫性重症肌无力大鼠(其乙酰胆碱受体减少是由自身抗体攻击所致)肌肉终板处的体外乙酰胆碱释放。在人类和大鼠自身免疫性重症肌无力肌肉中,平均量子含量与对照水平相比显著增加。在每个单独的重症肌无力终板处,量子含量的增加似乎与微小终板电位幅度的降低相关。这一发现表明重症肌无力中存在一种重要的代偿机制,其中逆向作用因子(即从肌纤维到神经末梢)上调乙酰胆碱释放。

相似文献

1
Acetylcholine release in myasthenia gravis: regulation at single end-plate level.重症肌无力中的乙酰胆碱释放:单终板水平的调节
Ann Neurol. 1995 May;37(5):627-36. doi: 10.1002/ana.410370513.
2
Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.先天性肌无力:5例终板乙酰胆碱受体与电生理研究
Muscle Nerve. 1981 Jul-Aug;4(4):306-18. doi: 10.1002/mus.880040407.
3
Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.慢性实验性自身免疫性重症肌无力大鼠膈肌中乙酰胆碱的释放
Ann Neurol. 1978 Jul;4(1):67-72. doi: 10.1002/ana.410040113.
4
Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.重症肌无力中的乙酰胆碱受体:对α-银环蛇毒素的亲和力增加。
Ann Neurol. 1978 Sep;4(3):250-2. doi: 10.1002/ana.410040310.
5
End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.终板电压门控钠通道在临床和实验性重症肌无力中缺失。
Ann Neurol. 1998 Mar;43(3):370-9. doi: 10.1002/ana.410430315.
6
Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.单克隆抗乙酰胆碱受体抗体诱发的肌无力:临床和电生理方面
Ann Neurol. 1981 Jun;9(6):563-8. doi: 10.1002/ana.410090609.
7
A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.一种新的肌无力综合征,伴有终板乙酰胆碱酯酶缺乏、神经末梢细小及乙酰胆碱释放减少。
Ann Neurol. 1977 Apr;1(4):315-30. doi: 10.1002/ana.410010403.
8
Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.重症肌无力及其实验性自身免疫模型中乙酰胆碱受体的超微结构定位
Neurology. 1977 Apr;27(4):307-15. doi: 10.1212/wnl.27.4.307.
9
Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.肌肉中rapsyn表达的增加可防止实验性自身免疫性重症肌无力中乙酰胆碱受体的丢失。
Brain. 2005 Oct;128(Pt 10):2327-37. doi: 10.1093/brain/awh612. Epub 2005 Sep 8.
10
Acetylcholinesterase activity of skeletal muscle in a non-immunogenic model for myasthenia gravis in rats.大鼠重症肌无力非免疫原性模型中骨骼肌的乙酰胆碱酯酶活性
J Neural Transm (Vienna). 1999;106(5-6):423-31. doi: 10.1007/s007020050169.

引用本文的文献

1
AChR-blocking antibodies and complement system dynamics: evaluating their interplay and clinical implications in myasthenia gravis.乙酰胆碱受体阻断抗体与补体系统动力学:评估它们在重症肌无力中的相互作用及临床意义。
Neurol Sci. 2025 Apr;46(4):1827-1832. doi: 10.1007/s10072-024-07889-8. Epub 2024 Dec 16.
2
Modeling neuromuscular diseases in zebrafish.在斑马鱼中模拟神经肌肉疾病
Front Mol Neurosci. 2022 Dec 13;15:1054573. doi: 10.3389/fnmol.2022.1054573. eCollection 2022.
3
Opposite Regulation of Homer Signal at the NMJ Postsynaptic Micro Domain between Slow- and Fast-Twitch Muscles in an Experimentally Induced Autoimmune Myasthenia Gravis (EAMG) Mouse Model.
实验性自身免疫性重症肌无力(EAMG)小鼠模型中快肌和慢肌 NMJ 突触后微区 Homer 信号的相反调节。
Int J Mol Sci. 2022 Nov 30;23(23):15052. doi: 10.3390/ijms232315052.
4
Homeostatic Plasticity of the Mammalian Neuromuscular Junction.哺乳动物神经肌肉接点的自稳态可塑性。
Adv Neurobiol. 2022;28:111-130. doi: 10.1007/978-3-031-07167-6_5.
5
Structure and Function of the Mammalian Neuromuscular Junction.哺乳动物神经肌肉接头的结构与功能。
Compr Physiol. 2022 Aug 11;12(4):3731-3766. doi: 10.1002/cphy.c210022.
6
Congenital myasthenic syndrome due to a mutation: a new disease pathway for impaired synaptic transmission.由突变引起的先天性肌无力综合征:突触传递受损的新疾病途径。
Brain Commun. 2020 Oct 18;2(2):fcaa174. doi: 10.1093/braincomms/fcaa174. eCollection 2020.
7
Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China.中国东北地区肌肉特异性激酶(MuSK)抗体阳性重症肌无力的区域特征
Front Neurol. 2020 Oct 2;11:516211. doi: 10.3389/fneur.2020.516211. eCollection 2020.
8
Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.重症肌无力:从致病性角度看,聚焦于乙酰胆碱受体聚集、跨突触稳态和突触稳定性
Front Mol Neurosci. 2020 May 28;13:86. doi: 10.3389/fnmol.2020.00086. eCollection 2020.
9
Muscle-Specific Kinase Myasthenia Gravis.肌肉特异性激酶重症肌无力。
Front Immunol. 2020 May 8;11:707. doi: 10.3389/fimmu.2020.00707. eCollection 2020.
10
The Muscle Is Not a Passive Target in Myasthenia Gravis.在重症肌无力中,肌肉并非被动靶点。
Front Neurol. 2019 Dec 19;10:1343. doi: 10.3389/fneur.2019.01343. eCollection 2019.